Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-13 · accession 0001209191-23-037387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-06-15 | 2023-06-13 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $84.83 | -27.1K | 51.9K | -34% | -$2.30M |
| DI | 2023-06-15 | 2023-06-13 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $42.98 | +27.1K | 79.0K | +52% | +$1.16M |
| DI | 2023-06-15 | 2023-06-13 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | -27.1K | 135.7K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-13 | S | D | 27,090 | $84.83 | 51,879 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | — | — | (F1) The shares were sold in multiple transactions at prices ranging from $84.19 to $85.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Class A Common Stock | 2023-06-13 | M | A | 27,090 | $42.98 | 78,969 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-06-13 | M | D | 27,090 | $0.00 | 135,696 | I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 | $42.98 · — to 2024-12-15 | 27,090 Class A Common Stock | (F3) This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |